Search

everythinglearnresearchcommunity

for

Search:↓

The workshop aimed to improve hair loss disorder diagnosis and understanding.

Early treatment helps stop hair loss in women of color.

Middle-aged women in Iran are most affected by primary cicatricial alopecia, especially discoid lupus erythematous.

A condition with certain scalp changes may come before acne keloidalis nuchae and other similar hair loss disorders.

Early detection and histopathology are crucial to prevent permanent hair loss in cicatricial alopecia.

Early treatment is key for permanent hair loss disorders, with options ranging from medications and phototherapy to immunomodulators and antibiotics, depending on severity and type.

A condition called Central Centrifugal Cicatricial Alopecia causes hair loss and scalp burning in middle-aged African women, and it's treated with various medications, hair transplants, and non-drug methods like wigs.

Cicatricial pattern hair loss is likely advanced common baldness, not a type of lichen planopilaris.

Elastin staining helps assess late-stage scarring alopecia but is not definitive, and clinical diagnosis is still crucial.

Hair restoration surgery can potentially treat primary scarring alopecias, but it's important to start early medication, ensure patient remission before transplant, and monitor after surgery.

The document concludes that more research is needed to better understand and treat primary cicatricial alopecias, and suggests a possible reclassification based on molecular pathways.

There are many treatments for permanent hair loss disorders, but their effectiveness varies and there's no clear best option.

New understanding of the causes of primary cicatricial alopecia has led to better diagnosis and potential new treatments.

Certain mouse strains develop a skin condition similar to a human hair loss disease due to genetic defects.

PPAR-γ helps control skin oil glands and inflammation, and its disruption can cause hair loss diseases.

PRP shows promise for treating mild alopecia areata but needs more research for cicatricial alopecias.

Primary cicatricial alopecia, a rare disorder causing permanent hair loss, is hard to diagnose and treat, with treatments like anti-inflammatory drugs and steroids offering varied results and no guaranteed cure. Psychological support for patients is important, and future research should aim to identify causes of the condition.

Platelet-Rich Plasma (PRP) may help improve hair density in primary cicatricial alopecias (PCAs) patients, but more trials are needed to confirm its benefits.

Systemic mastocytosis may cause a type of hair loss called cicatricial alopecia.

Hair transplantation may work for some types of scarring alopecia, but results vary and more research is needed.

CCCA is a scarring hair loss condition mainly in African descent women, possibly caused by genetics and hairstyling, treated with gentle hair care and medications.

Cholesterol-related compounds can stop hair growth and cause inflammation in a type of scarring hair loss.

Lichen planopilaris is the most common type of scarring hair loss observed, with a variety of symptoms and tissue changes.

Cicatricial alopecia involves scarring hair loss and can be treated with various medications.

The document concludes that primary scarring alopecias cause permanent hair loss, have unpredictable outcomes, and lack definitive treatments, requiring personalized care.

Hair transplants can be a treatment for scarring hair loss if there's good blood flow and no active disease.

The "spade sign" is a highly specific indicator for diagnosing acne keloidalis.

Oral dutasteride can potentially treat frontal fibrosing alopecia in postmenopausal women, with some patients showing disease arrest and hair regrowth.

Frontal fibrosing alopecia is a scarring hair loss condition mainly affecting older women, with no known cause and treatments that may help stabilize hair loss.

Disrupted cholesterol production impairs hair follicle stem cells, leading to hair loss.